Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials

BACKGROUND: Many Chinese patent medicines (CPMs) have been authorized by the Chinese State of Food and Drug Administration for the treatment of the common cold. A number of clinical trials have been conducted and published. However, there is no systematic review or meta-analysis on their efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Liu, Bo, Wang, Li-qiong, Ren, Jun, Liu, Jian-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129119/
https://www.ncbi.nlm.nih.gov/pubmed/25074623
http://dx.doi.org/10.1186/1472-6882-14-273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129119/
https://www.ncbi.nlm.nih.gov/pubmed/25074623
http://dx.doi.org/10.1186/1472-6882-14-273

Ejemplares similares